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During endochondral bone formation, chondrocytes in the cartilaginous anlage of long bones progress through a spatially
and temporally regulated differentiation program before being replaced by bone. To understand this process, we have
characterized the differentiation program and analyzed the relationship between chondrocytes and their extracellular
environment in the regulation of the program. Our results indicate that, within an epiphyseal growth plate, the zone of
proliferating chondrocytes is not contiguous with the zone of hypertrophic chondrocytes identi®ed by the transcription of
the type X collagen gene. We ®nd that the postproliferative chondrocytes which make up the zone between the zones of
proliferation and hypertrophy speci®cally transcribe the gene for cartilage matrix protein (CMP). This zone has been termed
the zone of maturation. The identi®cation of this unique population of chondrocytes demonstrates that the chondrocyte
differentiation program consists of at least three stages. CMP translation products are present in the matrix surrounding
the nonproliferative chondrocytes of both the zones of maturation and hypertrophy. Thus, CMP is a marker for postmitotic
chondrocytes. As a result of the changes in gene expression during the differentiation program, chondrocytes in each zone
reside in an extracellular matrix with a unique macromolecular composition. Chondrocytes in primary cell culture can
proceed through the same differentiation program as they do in the cartilaginous rudiments. In culture, a wave of differentia-
tion begins in the center of a colony and spreads to its periphery. The cessation of proliferation coincides with the appearance
of CMP and eventually the cells undergo hypertrophy and synthesize type X collagen. These results reveal distinct switches
at the proliferative±maturation transition and at the maturation±hypertrophy transition during chondrocyte differentiation
and indicate that chondrocytes synthesize new matrix molecules and thus modify their preexisting microenvironment as
differentiation progresses. However, when ``terminally'' differentiated hypertrophic chondrocytes are released from their
surrounding environment and incubated in pellet culture, they stop type X collagen synthesis, resume proliferation, and
reinitiate aggrecan synthesis. Eventually they cease proliferation and reinitiate CMP synthesis and ®nally type X collagen.
Thus they are capable of recapitulating all three stages of the differentiation program in vitro. The data suggest a high
degree of plasticity in the chondrocyte differentiation program and demonstrate that the progression and maintenance of
this program is regulated, at least in part, by the extracellular environment which surrounds a differentiating chondrocyte
during endochondral bone formation. q 1995 Academic Press, Inc.
INTRODUCTION cursor cells differentiate into chondrocytes of the cartilagi-
nous growth plate and they progress through a chondrocyte
differentiation program, starting as proliferating chondro-Cartilaginous rudiments of a developing embryo serve as
cytes and ending up as hypertrophic chondrocytes. The hy-anlagen from which long bones are formed during endo-
pertrophic chondrocytes are then removed and replaced bychondral bone formation. During this process the length
bone. The chondrocyte differentiation program has beenand shape of a bone is determined. Limb mesodermal pre-
partitioned into different stages based on cell shape and
volume, biosynthetic and metabolic activities, and, most
accurately, on molecular markers. At least two models have1 To whom correspondence should be addressed. Fax: (617) 726
4189. been proposed. According to one model (Castagnola et al.,
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1988) the differentiation program is divided into two stages gaÊrd, 1981). It contains two homologous repeats (CMP-like
domains) that are separated by an EGF-like domain (Ar-and the chondrocytes are considered to be either in the
proliferative or in the hypertrophic state. Thus, this model graves et al., 1987; Kiss et al., 1989). CMP-like domains
have also been found in collagen types VI, VII, XII, and XIV;proposes that the proliferative stage immediately precedes
the hypertrophic stage during endochondral bone forma- von Willebrand factor; complement factors B and C2; the a
chains of the integrins Mac-1, p150/95, LFA-1, and VLA-2;tion. The proliferating chondrocytes synthesize type II col-
lagen and aggrecan (Miller, 1972; Doege et al., 1990). These malaria thrombospondin-related anonymous protein; dihy-
dropyridine-sensitive calcium channel; and inter-a-trypsinmarkers distinguish the chondrocytes from their mesoder-
mal precursors which synthesize type I collagen. The hyper- inhibitor (Winterbottom et al., 1992; Yamagata et al., 1991;
Gerecke et al., 1993; Parente et al., 1991; Bork and Rohde,trophic chondrocytes produce type X collagen, a hypertro-
phic cartilage-speci®c molecule (Schmid and Conrad, 1982; 1991). In the matrix of cartilage, CMP interacts with colla-
gen ®brils (Winterbottom et al., 1992) and proteoglycansCapasso et al., 1984). The second model proposes that the
chondrocytes of the growth plate are divided into three dis- (Paulsson and HeinegaÊ rd, 1979). The collagen binding of
CMP has been localized to the CMP domains. Thus, it hastinct stages that are identi®ed histologically as the zones of
proliferation (zone 1), maturation (zone 2), and hypertrophy been suggested that CMP may be involved in collagen ®-
brillogenesis and in the organization of the matrix of carti-(zone 3) (Kim and Conrad, 1977; Stocum et al., 1979). Ac-
cording to this model, the transition of the chondrocytes lage (Tondravi et al., 1993).
The results of the present study indicate that the CMPfrom the zone of proliferation to the zone of hypertrophy
would be separated by an additional developmental stage, gene is transcribed only in the postproliferative chondro-
cytes in a zone between the zones of proliferation and hyper-the stage of maturation. However, no speci®c molecular
markers have been identi®ed for chondrocytes in this stage. trophy of the growth plate. CMP translation products are
present in the matrix surrounding the nonproliferativeThe molecular markers that characterize the differenti-
ated state of chondrocytes are extracellular matrix (ECM) chondrocytes of both the zones of maturation and hypertro-
phy. Thus, CMP is a marker for postmitotic chondrocytes.macromolecules and the chondrocyte differentiation pro-
cess is modulated by extracellular cues including the ECM As a result of the changes in gene expression during the
differentiation program, chondrocytes in each zone reside(Benya and Schaffer, 1982; von der Mark et al., 1992b). In
monolayer culture, chondrocytes which are seeded at low in an extracellular matrix with a unique macromolecular
composition. Chondrocytes in cell culture proceed throughdensity will transform their chondrogenic phenotype (round
shape, type II collagen synthesis) to a ®broblastic one (¯at- the same temporal progression of proliferation, maturation,
and hypertrophy in that CMP is produced by postprolifera-tened morphology, type I collagen synthesis) under certain
conditions (von der Mark et al., 1977). This transformation tive chondrocytes before type X collagen is synthesized.
Finally, hypertrophic chondrocytes that are released fromdepends on cell shape and attachment, which is mediated
through cell±matrix interaction (Benya and Schaffer, 1982). their surrounding environment are capable of recapitulating
all three stages of the differentiation program in vitro.The alteration of the chondrocyte differentiation process
also occurs in vivo. For example, articular cartilage nor-
mally does not undergo endochondral bone formation.
However, in the osteoarthritic articular cartilage where the MATERIALS AND METHODS
matrix is destroyed, chondrocytes resume proliferation and
type X collagen, a hallmark of cartilage hypertrophy, is syn- Cell and Organ Culture
thesized (von der Mark et al., 1992b). Thus, hypertrophy of
chondrocytes is reinitiated (Hoyland et al., 1991). It is un- Primary cultures of chondrocytes were established as de-
scribed by Schmid and Conrad (1982). Brie¯y, tibiotarsiclear what determines chondrocytes to undergo regenera-
tion, dedifferentiation, or hypertrophy (von der Mark et al., were dissected from stage 41 (15th day of incubation) chick
embryos (Hamburger and Hamilton, 1951). The bone shell1992a).
There are three major types of ECM molecules in carti- and the tarsus region were separated from the cartilaginous
growth plate and discarded. To ensure that the selected re-lage: collagens, proteoglycans, and noncollagenous glyco-
proteins. That these macromolecules play an important gions of chondrocytes were derived from the desired zone,
only cells at the center of any one zone were used for cellmorphogenetic role during endochondral bone formation is
demonstrated most strikingly by the analysis of mutations or pellet culture. The cells at the boundary with neighboring
zones were discarded. In addition, control experiments werewhich alter the expression of the genes of aggrecan core
(Argraves et al., 1981; Goetinck, 1991) and collagens type carried out by immunostaining with mAbs, to ensure that
a cartilage piece was only positive for the molecular markerII (Bogaert et al., 1992; Garofalo et al., 1991, 1993; Metsa-
ranta et al., 1992), type IX (Nakata et al., 1993), and type X that is characteristic for chondrocytes of the desired zone.
For organ culture, cartilage explants are cultured in Ham(Jacenko et al., 1993). As part of this study we investigated
the gene expression of cartilage matrix protein (CMP) during F-12 medium containing 10% fetal calf serum (plating me-
dium) (Gibco, Grand Island, NY) at 377C in an atmosphereendochondral bone formation. CMP is a major noncollage-
nous protein in the matrix of cartilage (Paulsson and Heine- of 5% CO2 . For monolayer cell culture and pellet mass
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culture, a piece of cartilage from a de®ned zone was sub- the tissue. Different labeling time periods were tested. One
hour was the minimum time for intensive labeling. For celljected to enzymatic treatment with 0.1% trypsin (Sigma,
St. Louis, MO), 0.3% collagenase (Worthington, Freehold, culture labeling, BrdU (1 mM) is added to cell culture 1 hr
before immunostaining.NJ), and 0.1% type I testicular hyaluronidase (Sigma) (disso-
ciation medium). After an incubation of 30 min at 377C this
dissociation medium was removed and replaced with fresh
Immunocytochemistry and Histochemistrydissociation medium and incubated at 377C for an addi-
tional hour. For monolayer cell culture, chondrocytes were Tissue embedding, processing for cryostat sectioning, and
indirect immuno¯uorescence for immunocytochemicalresuspended in plating medium containing 0.01% testicular
hyaluronidase. After culturing overnight, the medium of analyses were performed as described by Fitch et al. (1982).
For double immuno¯uorescence staining, cultured cellsthe chondrocytes was replaced with fresh medium without
hyaluronidase. The medium was changed every other day. were ®xed at 0207C with 70% ethanol, 50 mM glycine, pH
2.0, for 20 min. Slides were then washed with phosphate-Pellet mass cultures were performed as described by Kato
et al. (1988). Brie¯y, chondrocytes were washed and pelleted buffered saline (PBS) and incubated with primary antibod-
ies. After washing with PBS, secondary antibodies were ap-at 1000g in a 15-ml plastic centrifuge tube and incubated
in plating medium at 377C. plied together with Hoechst nuclear dye. Slides were
washed and mounted in 95% glycerol in PBS. Double or
triple exposure photography was performed with a micro-Determination of DNA Content scope from Nikon.
The monoclonal antibody against CMP, 1H1/E2, wasDNA content from organ or pellet mass cultures was de-
termined as described by Labarca and Paigen (Labarca and generated as described in detail by Binette et al. (1994).
1H1/E2 (IgG1, k) recognizes puri®ed chick CMP (100 mg/Paigen, 1980). Brie¯y, a piece of cartilage or cell pellet was
homogenized in phosphate-saline buffer (PSEB: 0.05 M ml) in ELISA up to a dilution of 1005 of ascites ¯uid and
does not recognize puri®ed chick collagen type II or puri-Na2HPO4, 2 M NaCl, 0.003 M EDTA, pH 7.4), and sonicated
brie¯y. Hoechst nuclear dye (Polysciences, Inc., War- ®ed chick link protein. 1H1/E2 also recognizes CMP as a
single band of 54 kDa (Winterbottom et al., 1992), whenrington, PA) was added in 1:100 dilution in PSEB and incu-
bated at room temperature for 1 hr. Fluorescence was mea- total proteins from cartilage extracts are electrophoresed
on 8% SDS±PAGE gels under reducing conditions. Thesured with a TKO 100 ¯uorometer from Hoefer (San
Francisco, CA). DNA standards were used and the determi- other mAbs employed recognize link protein (4B6/A5; Bi-
nette et al., 1994), type II collagen (II-II 6B3; Hendrix etnations were made in the linear range of the curve.
al., 1982), and a helical determinant in type X collagen (X-
AC9; Schmid and Linsenmayer, 1985). The mAb against
In Situ Hybridization BrdU was purchased from Boehringer-Mannheim. The
polyclonal antibodies (RC1) were generated in rabbitIn situ hybridization for mRNAs encoding aggrecan core
protein, link protein, CMP, and type X collagen were per- against puri®ed chicken CMP. They were characterized
by both ELISA and Western blot analysis as recognizingformed according to Hayashi et al. (1986) and Linsenmayer
et al. (1991). The slides were viewed by dark-®eld and CMP speci®cally. Af®nity-puri®ed rhodamine or ¯uo-
rescein-conjugated secondary antibody was purchasedbright-®eld optics and photographed on a Microphot-FXA
microscope from Nikon (Melville, NY). The probe for CMP from Jackson ImmunoResearch (West Grove, PA).
was CMP 1 (Argraves et al., 1987). The probe for aggrecan
core protein was PG 525 (Stirpe et al., 1987). The link pro-
Western Blot Analysistein probe was LPG2 (DeaÂk et al., 1986). The type X collagen
probe was a PstI/PvuII fragment of pYN 3116 (Ninomiya et Chick sterna were homogenized in 4 M urea, 50 mM Tris
at pH 7.5. The homogenate was centrifuged and the amountal., 1986).
of protein in the supernatant was measured by the optical
density of the sample at 280 nm. Five micrograms of each
BrdU Incorporation and Detection supernatant were analyzed on a discontinuous 8% SDS±
PAGE. The proteins were transferred onto Immobilon±Incorporation and detection of BrdU in cartilage tissues
were performed with the 5-bromo-2*-deoxyuridine labeling PVDF membrane (Millipore Corp., Bedford, MA) in 25 mM
Tris, 192 mM glycine, 15% methanol. The membranes wereand detection kit II from Boehringer-Mannheim (Indianapo-
lis, IN). Labeling cartilage with BrdU was carried out in ovo blocked in 2% bovine serum albumin fraction V (Sigma) in
PBS for 30 min and then probed with the anti-CMPor in vitro. Both methods gave identical results. For in ovo
labeling, 40 ml of BrdU (1 ml/g of body weight) were injected mAb1H1/E2, or with a polyclonal Ab EM 77 against type
X collagen (Paci®ci et al., 1991). Horseradish peroxidase-into the aircell of an egg 3 hr before dissection. For in vitro
tissue labeling, a tibiotarsus was dissected out of the embry- conjugated goat anti-mouse IgG (H / L) or anti-rabbit IgG
(Bio-Rad Lab, Melville, NY) was used as a secondary anti-onic chick leg. Perichondrium and bone shell were then
peeled from the cartilage to ensure penetration of BrdU into body. Visualization of the immunoreactive proteins was
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achieved using the ECL Western blotting detection reagents
(Amersham Corp., Heights, IL) and exposing the membrane
to Kodak X-Omat AR ®lm.
RESULTS
The CMP Gene Is Transcribed Only by
Chondrocytes of the Zone of Maturation
To identify different stages in the chondrocyte differentia-
tion program, we used the incorporation of BrdU to visual-
ize proliferating chondrocytes, and probes that allowed the
determination of the transcriptional activity of a number
of genes that encode ECM molecules. A bright-®eld histo-
logical section of a growth plate of a stage 41 embryo is
shown in Fig. 1A. Histologically identi®able zones are indi-
cated. Incorporation of BrdU by the nuclei identi®es the
zone of proliferation (P) at the distal end of the tibia (Fig.
1B). Chondrocytes in this region (zone 1) are small and
round, with many mitotic ®gures in the nuclei (Fig. 2, 1).
In the zone of hypertrophy (zone 3), the size of the cells is
dramatically increased (Fig. 2, 3). This zone (H) is character-
ized by the presence of the mRNA for type X collagen (Fig.
1F), a hypertrophic cartilage-speci®c molecule (Schmid and
Linsenmayer, 1983). A comparison of Figs. 1B and 1F indi-
cates that the proliferative zone is not contiguous with the
hypertrophic zone. Therefore, there exists an additional
zone between the zones of proliferation and hypertrophy.
This zone corresponds to the histologically identi®ed zone
of maturation (Kim and Conrad, 1977; Stocum et al., 1979)
and the CMP gene is transcribed only by chondrocytes in
this zone (M) (Fig. 1C). Flattened cells at the beginning of
this zone (2a) give rise to medium-sized cells toward the
end of the zone (2b), ful®lling the transition from the prolif-
erating to the hypertrophic state (see Figs. 1A and 2, 2a and
2b). Transcripts for aggrecan core protein and link protein FIG. 1. Micrographs of sections of a tibiotarsus from a stage 41
are present in chondrocytes of both the proliferative zone chick embryo. Bright-®eld histochemical staining (H&E) (A), im-
and the zone of maturation, but not in those of the zone of muno¯uorescence micrograph with a mAb against incorporated
BrdU (B), and dark-®eld micrographs of in situ hybridizations withhypertrophy (Figs. 1D and 1E). Thus, the spatially restricted
cDNAs for CMP (C), the core protein of aggrecan (D), link proteintranscriptional activity of the CMP gene in the growth plate
(E), and type X collagen (F). P and 1, zone of proliferation (zone 1);indicates that the chondrocytes situated between the chon-
M and 2, zone of maturation (zone 2); 2a, ®rst half of the maturedrocytes that make up the zones of proliferation and hyper-
zone; 2b, second half of the mature zone; H and 3, zone of hypertro-trophy are a unique population of cells. These observations
phy (zone 3). Bar, 400 mm.
clearly establish the presence of at least three stages in the
differentiation program of chondrocytes.
re¯ecting the rapid appositional growth of the rudimentThe Translation Product of the CMP Gene Is a
(Fig. 3A). Proliferating cells of the blood or bone marrowMarker for Postproliferative Chondrocytes
could also be identi®ed (Fig. 3A, white arrows). CMP could
be shown by immuno¯uorescence to be present in the twoThe distribution of ECM proteins and incorporated BrdU
was examined in sections from the tibiotarsus of a stage 45 postproliferative zones of maturation and hypertrophy as
well as in the tarsus (Fig. 3C). CMP is absent not only fromchick embryo. BrdU labeling (Fig. 3A) revealed a zone of
proliferating chondrocytes in the epiphyseal growth plate. the proliferative zone, but also from the proliferating chon-
drocytes at the perimeter of the tibia (compare Figs. 3C andAt this stage the proliferative zone is shorter than the one
at stage 41 (compare Figs. 3A and 1B). There are many prolif- 3A). Type X collagen was present only in the hypertrophic
zone (Fig. 3D). In contrast to the speci®c localization oferating chondrocytes at the perimeter of the growth plate,
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FIG. 2. Morphology of chondrocytes during in vivo differentiation in the growth plate of a stage 41 embryonic chick tibiotarsus (bottom)
compared with the changes of the proliferative zone explants incubated in culture (top). The sections are from the proliferative zone (1),
®rst half of the mature zone (2a), second half of the mature zone (2b), and the hypertrophic zone (3) in vivo or the explant from the
proliferative zone incubated in culture for 1 hr (1h), 20 hr (1d), and 5 days (5d). All the sections are stained with hematoxylin and eosin.
Arrows in (1) indicate dividing chondrocytes. Bar, 10 mm.
CMP and type X collagen, link protein was detected Spatial and Temporal Expression of the
throughout the growth plate (Fig. 3B). Both CMP and link Differentiation Program in Primary Chondrocyte
protein were present in the matrix surrounding chondro- Cultures
cytes of the hypertrophic region even though the genes for
To test whether the spatial organization of chondrocytesthese proteins are not transcribed by the chondrocytes of
into distinct zones in vivo re¯ects the manifestation of theirthat zone (Figs. 3C and 3B). Thus, the translation product
differentiation process temporally, we examined the differ-of the CMP gene is a marker for nonproliferating chondro-
entiation time sequence of chondrocytes in monolayer cellcytes of either the mature or the hypertrophic zone. These
culture. Chondrocytes were isolated from the core of theresults indicate that the synthetic repertoire of chondro-
proliferative zone of tibiae from stage 41 chick embryos andcytes changes as differentiation proceeds and, as a result, the
cultured. After 3 days of culture, CMP can be detected incomposition of matrix is modi®ed during the progression of
the differentiation program. the cultures, but only in a subset of the chondrocytes. The
FIG. 3. Fluorescence micrographs of sections from a tibiotarsus of a stage 45 chicken embryo. Reactions with monoclonal antibodies
against incorporated BrdU (A), link protein (B), CMP (C), and type X collagen (D) are shown. P, zone of proliferation; M, zone of maturation;
H, zone of hypertrophy. White arrows point to the proliferation of cells from blood or bone marrow. Bar, 300 mm.
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FIG. 4. Fluorescence staining of primary cultures of chondrocytes isolated from the proliferative zone of the epiphyseal growth plate.
The presence of the cells are indicated by the blue nuclei staining with the Hoechst dye. (A, B, and C) From 3-day cultures. (D) is from
a 15-day culture. (A) Cells stained with mAb 1H1/E2 against CMP (red). Notice the red staining only in the center of the colonies. (B)
Cells doubly stained with mAb II-II 6B3 against type II collagen (red) and RC-1 against CMP (green). The solid arrow points to the type
II collagen staining in the cells. The open arrow points to the CMP staining. The overlapping region of type II (red) and CMP (green) is
yellow, which is only at the center of the colony. (C) Cells doubly stained with anti-BrdU (red) and RC1 against CMP (green). The solid
arrow points to the BrdU staining in the nuclei of the cells at the periphery of the colony, suggesting that they are proliferating cells. The
open arrow points to the blue nuclei (BrdU negative) in the center of the colony. These cells are CMP positive (green). (D) Chondrocytes
after 15 days of culture. Only part of a colony is shown. Cells doubly stained with RC1 against CMP (green) and mAb X-AC9 against
type X collagen (red). The solid arrow points to the ®lamentous staining of CMP connecting the cells in the colony. The open arrow
points to the punctate staining of type X collagen in the center of the colony. Bar, 225 nm.
CMP-positive cells are located at the center of the colonies extracellular space as ®lamentous material throughout the col-
onies (Fig. 4D). At this time, type X collagen can be detected(Fig. 4A). The cells at the periphery of the colonies do not
stain for CMP. The CMP distribution pattern is in contrast as punctate ¯uorescence signals within the colonies. Thus, in
the culture system, the chondrocytes go through the same dif-to that of type II collagen, which can be detected in the
cells throughout the colonies (Fig. 4B). To test whether the ferentiation program as they do in vivo. A wave of differentia-
tion spreads from the center of the colonies to the peripheryCMP-negative cells at the periphery are in fact the prolifer-
ating chondrocytes, the cultures were incubated in the pres- as proliferative cells differentiate into mature and subsequently
into hypertrophic chondrocytes.ence of BrdU for 1 hr. The peripheral cells which lack CMP
actively incorporate BrdU (Fig. 4C), indicating that they are
proliferating chondrocytes. BrdU incorporation cannot be
Removal of the Extracellular Environment fromdetected in the chondrocytes at the center of the colonies
Proliferative Chondrocytes Prolongs Theirwhich produce CMP (Fig. 4C), indicating that these are post-
Proliferation and Delays Their Maturationproliferative cells. After 15 days of incubation, chondro-
cytes have stopped dividing, as indicated by the lack of BrdU The data presented above suggest that there is a correla-
tion between the state of differentiation of chondrocytesincorporation (data not shown). CMP is laid down in the
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FIG. 5. Diagram describing the method used to generate differentiation stage-speci®c organ cultures and pellet mass cultures. P, prolifera-
tive zone; M, mature zone; H, hypertrophic zone. These three zones were separated by microdissection. The cartilage explants were either
directly incubated as organ cultures or digested with collagenase, testicular hyaluronidase, and trypsin to eliminate the extracellular
environment. These chondrocytes were washed and pelleted and incubated as pellet cell cultures. The proliferative zone and the hypertro-
phic zone were tested in this experiment.
and their ECM expression. To test if this state is directly as proliferating chondrocytes (Fig. 7A). There is little stain-
ing for the postmitotic chondrocyte marker CMP at the endin¯uenced by the extracellular environment surrounding
differentiating chondrocytes, an in vitro culture system was of the ®rst hour (Fig. 7B), and there is no staining for type
X collagen (data not shown). However, after 1 day of incuba-devised in which pieces of cartilage are taken from the core
of the zones of proliferation and hypertrophy (Fig. 5). In one tion (20 hr), there is strong staining for CMP (Fig. 7D), no
detectable BrdU incorporation (Fig. 7C), and still no stainingset of experiments the chondrocytes are maintained as an
isolated piece of cartilage surrounded by their original extra- for type X collagen (data not shown). These changes suggest
that the chondrocytes have differentiated to the stage ofcellular matrix (organ culture). These are compared with the
chondrocytes that are enzymatically removed from their maturation. Type X collagen can be ®rst detected at the 3rd
day of incubation (data not shown). After 5 days of incuba-surrounding matrix and cultured as a pellet mass culture
(pellet culture). The organ and pellet cultures were carried tion, type X collagen can be detected throughout the cul-
tured piece (Fig. 7F) and there is no BrdU incorporationout with chondrocytes that originated from the same region
of the growth plate. For each comparison, therefore, the detected (Fig. 7E), indicating that the chondrocytes have
reached the hypertrophic stage. The results also suggest thatchondrocytes are from the same developmental stage.
When a piece of cartilage from the proliferative zone is the constant level of DNA in the cultured pieces of cartilage
is the result of the maintenance of living cells and not themaintained as an organ culture in the presence of serum
the DNA content remains constant during 12 days of incu- result of a balance between proliferation and cell death. In
contrast, in organ cultures without serum, DNA content inbation (Fig. 6, solid squares). This observation indicates that
the chondrocytes have stopped proliferating in culture. The the cultured pieces decreases by 50% during incubation (Fig.
6, solid diamonds). However, in these cultures the chondro-morphology of the chondrocytes of the cartilaginous pieces
cultured for 1 hr, 1 day, or 5 days is very similar to that cytes go through the same differentiation sequence as the
cells cultured in the presence of serum (data not shown).seen in the mature (zones 2a and 2b) and the hypertrophic
(zone 3) zones, respectively (compare Fig. 2, 1h to 2a, 1d to Therefore, in organ culture, serum is necessary for pre-
venting cell death or tissue degradation, but not required2b, and 5d to 3). These changes in morphology suggest that
the chondrocytes have undergone differentiation in culture. for chondrocyte differentiation.
To compare quantitatively the appearance of CMP andThis rapid process of differentiation in vitro from the pro-
liferative through the mature to the hypertrophic stage was type X collagen during incubation of the cartilage explants
from the proliferative zone, an equal amount of extracts (5demonstrated at the molecular level by the incorporation of
BrdU (marker for proliferation) and the expression of CMP mg) from cartilage explants cultured for 0, 1, and 5 days are
analyzed by Western blot. As shown in Fig. 7G, a band of(marker for maturation) and type X collagen (marker for
hypertrophy) (Fig. 7). The incorporation of BrdU by the cells CMP trimers (200 kDa) is barely detectable at the beginning
of incubation (0 day). It is clearly detected after 1 day ofduring the ®rst hour of incubation con®rms their identity
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FIG. 6. Effects of serum and extracellular environment on the proliferation of primary chondrocytes derived from the proliferative zone.
A cartilage explant from zone 1 of a stage 41 chick growth plate was incubated in the presence (solid square) or absence (solid diamond)
of serum. Alternatively, the chondrocytes were released from their extracellular environment and incubated as a pellet culture in the
presence of serum (open square). The 100% value is the DNA content of a zone 1 cartilage explant at the beginning of incubation. The
curves are representative of three different experiments.
incubation and is present at the 5th day of incubation. In program, we examined, by in situ hybridization, the expres-
sion of the genes encoding aggrecan core protein and CMPcomparison, type X collagen (59 kDa) is not detected at
either 0 or 1 day of incubation, but is detected at the 5th during the incubation of the chondrocytes in pellet cultures.
These two genes are not active in hypertrophic chondro-day of incubation. Thus, when chondrocytes from the prolif-
erative zone are cultured as an organ, proliferation ceases cytes (Figs. 9A and 9B). At Day 4 of incubation, the tran-
scription of the genes for aggrecan core protein and CMP isand differentiation starts during the 1st day of incubation.
In contrast, in pellet mass cultures of proliferative chondro- reinitiated throughout the pellet mass culture derived from
the hypertrophic zone (Figs. 9D and 9E). The presence ofcytes that are removed from their extracellular environ-
ment, proliferation continues for 10 days (Fig. 6, open transcripts for aggrecan core protein is still present at Day
7 (Fig. 9G) and the transcription of CMP seems to reach asquare). These chondrocytes synthesize a new surrounding
matrix (data not shown) before undergoing subsequent mat- peak at this time. Both the density and intensity of the
grains for CMP (hybridization signals) increase (Fig. 9H).uration and hypertrophy. Therefore, the transient removal
of the extracellular environment from proliferating cells in This suggests that there is an elevation in the transcrip-
tional activity of the CMP gene by an increased number ofsitu prolongs the proliferative period and delays the progres-
sion of the differentiation program. cells. There is no longer any increase in DNA content (Fig.
8, open squares) at this time. In contrast, the transcription of
the type X collagen gene, a marker for hypertrophic cartilageHypertrophic Chondrocytes Can Recapitulate the (Fig. 9C), is greatly down-regulated at 4 days of incubation
Chondrocyte Differentiation Program (Fig. 9F). At Day 12 of incubation, the expression for type
X collagen is reinitiated (Fig. 9I). The histochemical stainingThe behavior of postmitotic, ``terminally'' differentiated
hypertrophic chondrocytes was examined in organ and in of a Day 12 pellet mass culture shows the de novo synthe-
sized matrix material that is deposited between the cellspellet mass cultures. Pieces of hypertrophic cartilage were
taken from the core of late hypertrophic zones. Chondro- by the chondrocytes during the incubation period (Fig. 9J,
arrow).cytes in these pieces are large in size (see Fig. 2) and they
actively transcribe the type X collagen gene (Fig. 9C). To The sections of the pellet cultures and organ cultures of
hypertrophic chondrocytes were examined by immuno-eliminate the complication of cell death, hypertrophic
chondrocytes were incubated only in serum containing me- staining with mAbs against incorporated BrdU and type X
collagen. At Day 4 of incubation, there are many BrdU-dium. In organ culture, the DNA content of the incubated
pieces of hypertrophic cartilage remains constant (Fig. 8, positive nuclei in the pellet culture (Fig. 10A) and none in
the organ culture (Fig. 10C). However, at Day 7 of incuba-solid squares). However, in pellet mass cultures, the postmi-
totic hypertrophic chondrocytes that were deprived of their tion, there are only a few BrdU-positive nuclei in the pellet
culture (Fig. 10E) and still none in the organ culture (Fig.extracellular surrounding in situ resume proliferation and
double their DNA content by 6 days (Fig. 8, open squares). 10G). These results con®rm the measurement of DNA con-
tent in both pellet and organ cultures (Fig. 8). Furthermore,To determine if the resumption of proliferation represents
the beginning of the recapitulation of the differentiation type X collagen is distributed throughout both pellet and
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content and incorporation of BrdU), maturation (CMP ex-
pression), and hypertrophy (type X expression).
DISCUSSION
The Cellular Organization of the Growth Plate
The chondrocytes of the growth plate progress through
a differentiation program which can be partitioned into a
number of stages. These stages are clearly re¯ected in the
spatial organization of the chondrocytes in the different
zones of the growth plate. The generally accepted model,
as presented in many textbooks (Ross and Romrell, 1989;
Gilbert, 1994), describes the proliferative zone in a growth
plate as immediately preceding the hypertrophic zone. Our
study clearly shows that, at least in chick embryos, this is
not the case. The distribution of proliferating chondrocytes
in a growth plate was determined by monitoring the local-
ization of BrdU incorporated by dividing chondrocytes at
the G1-S phase transition. The zone of hypertrophic chon-
drocytes was identi®ed by the expression of type X collagen,
a commonly accepted marker of hypertrophic chondrocytes
(Schmid and Linsenmayer, 1983). Our results clearly indi-
cate that the proliferating chondrocytes make up a zone
which is not contiguous with the hypertrophic zone. There-
fore, there exists a population of nonproliferating chondro-
cytes that are not yet hypertrophic. Here we identify the
transcription of the CMP gene as a molecular marker for
chondrocytes of that zone. Our observations are consistent
with a second model which proposes that the chondrocytes
FIG. 7. Fluorescence micrographs of sections from the zone 1 car- of a growth plate are divided into at least three distinct
tilage explant cultured for 1 hr (A and B); 20 hr (C and D); and 5 stages that have been identi®ed histologically as the zones
days (E and F). Scale, 1:25. Sections were reacted with mAbs against of proliferation, maturation, and hypertrophy (Stocum et
incorporated BrdU (A, C, and E), against CMP (B and D), and against al., 1979; Oohira et al., 1974). The zones that we identify
type X collagen (F). (G) Western blot analysis of expression of CMP
and type X collagen by cartilage explants of the proliferative zone
cultured for 0, 1, and 5 days. Each lane contains 5 mg of protein
from extracts of cultured cartilage explants.
organ cultures (Figs. 10B, 10D, 10F, and 10H). Since tran-
scripts for type X collagen are present in the hypertrophic
chondrocytes at the beginning of incubation (Fig. 9C), but
are not detected in the pellet cultures at Day 4 of incubation
(Fig. 9F), type X collagen in the matrix of the pellet cultures
at Day 4 must have been synthesized by the cells which
are type X collagen mRNA-positive at the beginning of the
incubation. This con®rms the cells in the pellet culture
which are capable of proliferation as hypertrophic chondro-
FIG. 8. Effects of the extracellular environment on the prolifera-cytes. These data indicate that the nonproliferative termi-
tion of primary chondrocytes derived from the hypertrophic zone.nally differentiated hypertrophic chondrocytes have the ca-
A cartilage explant of zone 3 (solid square) or the cell pellet mass
pacity to undergo ``retrodifferentiation'' in response to derived from zone 3 (open square) was incubated in serum con-
changes in the extracellular environment. These cells are taining medium. The 100% value is the DNA content of a zone 3
then capable of recapitulating the differentiation program cartilage explant at the beginning of incubation. The curves are
representative of three different experiments.by reinitiating the stages of proliferation (increase of DNA
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ther by determining the pattern of transcription of genes
that encode chondrocyte matrix molecules. Our report is
the ®rst to identify CMP as a product of and a marker for
mature chondrocytes. A restricted pattern of expression of
the CMP gene in the growth plate has also been reported
in human and mouse (AszoÂ di et al., 1994; Mundlos and
Zabel, 1994). However, in both reports it is assumed that
the proliferative zone is contiguous with the hypertrophic
zone, and the zone of proliferation was not identi®ed experi-
mentally in either study. In human embryonic long bones
the mRNA for CMP was reported to be present in the upper
``hypertrophic'' and lower ``proliferative'' zone (Mundlos
and Zabel, 1994). This region is likely to correspond with
the zone of maturation as de®ned in the present study. In
another report (AszoÂ di et al., 1994) the expression of a
chicken genomic clone was monitored by immunohisto-
chemical means in transgenic mice. High levels of chicken
CMP were reported to be present in the zone of proliferating
chondrocytes and not in the zone of hypertrophic chondro-
cytes. It is dif®cult to compare the interpretation of these
results with those of the present study since the proliferat-
ing chondrocytes were not identi®ed in the transgenic ani-
mals. The reported absence of the translation product of the
chicken CMP gene in the hypertrophic zone of the
transgenic mice differs from our observation (Chen et al.,
unpublished) that mouse CMP is present in the hypertro-
phic region of normal mice.
It has been reported that CMP is not detected in the
super®cial layer of chondrocytes covering the joint articu-
lar surface (Franzen et al., 1987; Mundlos and Zabel, 1994),
but is detected in the deep layer of articular cartilageFIG. 9. Micrographs of sections of chondrocyte pellet mass cul-
(Mundlos and Zabel, 1994). This observation is reminis-tures. Bright-®eld micrographs of in situ hybridizations with cDNA
cent of the distribution pattern of CMP in the embryonicprobes for the core protein of aggrecan (A, D, and G), CMP (B, E, and
growth plate described here. Therefore, we suggest thatH), and type X collagen (C, F, and I). (A, B, and C) From hypertrophic
the difference in CMP distribution is due to the differentcartilage before culture; (D, E, and F) from 4-day cultures; (G and
H) from 7-day cultures; (I and J) from 12-day cultures. Bright-®eld stages of cartilage development, rather than the different
histochemical staining (H&E) of Day 12 culture (J). The arrow types of cartilage. Consistent with this idea are our previ-
points to the extracellular matrix areas between the chondrocytes. ous results (Stirpe and Goetinck, 1989), which indicated
Bar, 20 mm. that the transcripts for CMP are ®rst detected at stage 26
during chick limb development, later than those for type
II collagen (stage 23 and those for link protein and aggrecan
core protein (stage 25).as the zones of proliferation and maturation are referred to,
in the generally accepted model, as the resting zone and the
zone of proliferation, respectively. This discrepancy may The Differentiation Program of Chondrocytes
have resulted from a lack of appropriate markers for identi-
The results of the analysis of the spatial arrangement offying chondrocytes of the zones of proliferation, matura-
chondrocytes in the growth plate is corroborated by thetion, and hypertrophy when the ®rst model was proposed.
study of chondrocytes in monolayer cell culture in whichSince the de®nition of the developmental stages of the same
differentiation events happen sequentially. The analysis inregions of a growth plate differs between the two models,
vitro offered an advantage since immunostaining of chon-many studies on endochondral bone formation that use the
drocytes in culture allows the characterization of differenti-®rst model should be reinterpreted.
ation events in individual cells. Chondrocytes isolated from
the proliferative zone of the epiphyseal growth plate go
CMP Is a Molecular Marker of Cartilage through the stages of proliferation, maturation, and hyper-
Maturation trophy in vitro as they do in vivo. It is demonstrated by our
cell culture experiment that CMP is only made by thoseIn this study, we have characterized the molecular events
during the three stages of endochondral bone formation fur- cells that are no longer proliferating (lack of BrdU incorpora-
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FIG. 10. Immuno¯uorescence micrographs of sections from organ cultures or pellet mass cultures of hypertrophic chondrocytes. (A and B)
From 4-day pellet cultures; (C and D) from 4-day organ cultures; (E and F) from 7-day pellet cultures; (G and H) from 7-day organ cultures.
(A, C, E, and G) Reacted with a mAb against BrdU; (B, D, F, and H) reacted with X-AC9, a mAb against type X collagen. Bar, 50 mm.
tion). Therefore, CMP contributes to the formation of the program. When chondrocytes undergo hypertrophy, the genes
that encode CMP, link protein, and aggrecan core protein arecartilage matrix established by postproliferative chondro-
cytes, before the matrix is further modi®ed by type X colla- repressed and the gene for type X collagen is activated. This
represents the third switch in the program. These threegen synthesized by hypertrophic chondrocytes. These re-
sults indicate that the properties of the cartilage matrix switches represent key transition points in chondrogenesis
and endochondral bone formation. The ®rst switch separateschange during the course of differentiation. Furthermore,
this modi®cation of the matrix is controlled, at least in chondrocytes from their mesodermal precursors and the sec-
ond switch separates proliferating chondrocytes from postmi-part, at the mRNA level. This is illustrated by the in situ
hybridization data of the exclusive synthesis of mRNA for totic mature chondrocytes. In the ``permanent'' cartilage such
as articular cartilage and the cartilage of the caudal portion ofCMP by mature chondrocytes and of mRNA for type X by
hypertrophic chondrocytes. the sternum, chondrocyte differentiation stops at the matura-
tion stage. If the third switch is activated, chondrocytes pro-The program of chondrocyte differentiation is summarized
in Fig. 11. When chondrogenesis is initiated, the genes for ceed to the hypertrophic stage. Therefore, this switch sepa-
rates the permanent cartilage from the transitional cartilagecollagens type II (Miller, 1972) and IX (Linsenmayer et al.,
1991), aggrecan core protein, and link protein (Figs. 1D and which serves as a model for endochondral bone formation.
1E) are activated and the gene for type I collagen is repressed
(Linsenmayer et al., 1973). The switch from mesodermal pre- The Chondrocyte Differentiation Programcursor cells to proliferating chondrocytes is the ®rst step in
Is Reversiblethe cartilage differentiation program. The gene for CMP is
activated when chondrocytes stop proliferating and undergo In the present study we also show that the chondrocyte
differentiation program is dynamic. It can be delayed, re-maturation. This step represents the second switch in the
FIG. 11. The chondrocyte differentiation program indicating possible points for dedifferentiation and retrodifferentiation. The relationship
of the program with the expression of genes encoding extracellular matrix molecules is indicated. AGG, aggrecan; LP, link protein; CMP,
cartilage matrix protein.
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II and X, Maurizio Paci®ci for the pAb against type X collagen, andversed, and recapitulated. Our data suggest that the sur-
Janet Cravens for the production of mAb against CMP. Supportedrounding extracellular environment is essential for main-
by NIH Grant HD 22016 to P.F.G. Q.C. is a recipient of a postdoc-taining the state of differentiation of chondrocytes. The ex-
toral fellowship from the Arthritis Foundation.tracellular cues from this microenvironment may include
both ECM molecules and growth factors. It has been shown
that growth factors such as TGF-b and b-FGF are important
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